Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUpland Resource Regulatory News (UPL)

Share Price Information for Upland Resource (UPL)

Share Price is delayed by 15 minutes
Get Live Data
2.925    -0.025 (-0.85%)
Bid:
2.85
Ask:
3.00
Spread: 0.15 (5.263%)
Market Cap: £50.93m
UPL Live PriceLast checked at - London Stock Exchange

Intraday Upland Resource Share Chart

Convertible Loan Notes Facility Allowed To Lapse

2 Jan 2019 07:00

RNS Number : 9072L
Upland Resources Limited
02 January 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN

This announcement is not an offer for sale, or a solicitation of an offer to acquire, securities in any jurisdiction, including in or into the United States, Canada, Australia, or Japan. Neither this announcement nor any part of it shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever.

2 January 2019

UPLAND RESOURCES LIMITED

("Upland" or the "Company")

CONVERTIBLE LOAN NOTES FACILITY ALLOWED TO LAPSE

Upland Resources Limited (LSE: UPL announces that the £3,500,000 Convertible Loan Notes Facility (the "Facility", as referred to in the Company's announcements of 8 March 2018 and 20 March 2018) lapsed on 31 December 2018 (in accordance with its terms) and without the Company calling on the Facility Providers of such Facility to subscribe for any of the £3,500,000 Convertible Loan Notes.

The successful £3,000,000 (gross) fundraising conducted in June 2018 when added to Upland's existing cash resources leads the Board of Directors of the Company to consider that the Company is now unlikely to need to have this facility available to it. The lapse of the Facility now, without Upland having made any call on it, means the Company will incur no further costs associated with the Facility.

As a result of the lapse of the Facility, no Convertible Loan Notes will be issued pursuant to the Facility and therefore no new shares of nil par value in the Company are capable of being issued on conversion of any such Convertible Loan Notes. The 'relevant period' (for the purposes of section 87(G)(3)(b) of the Financial Services and Markets Act 2000) in relation to the prospectus of the Company published on 18 June 2018 (the "Prospectus") has therefore come to an end and the Company is no longer under any obligation to publish any further supplementary prospectus in respect of the Prospectus even if a significant new factor or a material mistake or inaccuracy relating to the information included in the Prospectus (or any supplementary prospectus published in relation to it) arises or is noted after 31 December 2018.

 

 

This announcement contains inside information for the purposes of Article 7 of the Regulation (EU) No 596/2014 on market abuse

Contact details:

Upland Resources Limited

www.uplandres.com

Steve Staley, CEO

 

Tel: +44 (0) 7891 677 441

s.staley@uplandres.com

Optiva Securities Limited

Jeremy King (Corporate Finance)

Tel: +44 (0) 20 3137 1904

jeremy.king@optivasecurities.com

Christian Dennis (Corporate Broker)

Tel: +44 (0) 20 3411 1882

christian.dennis@optivasecurities.com

FTI Consulting

Ben Brewerton/Molly Stewart

Tel: +44 (0)203 727 1708

molly.stewart@fticonsulting.com

Flowcomms Ltd

Sasha Sethi

Tel: +44 (0) 7891 677441

sasha@flowcomms.com

Notes

Upland Resources Limited is an upstream oil & gas company whose highly experienced management team has a track record of creating major value for shareholders in junior oil & gas companies, including Cove Energy plc. The Company has extensive technical and commercial skills and contacts, management having held senior roles in Petronas, Conoco, Shell etc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGUQCGUPBUQP
Date   Source Headline
28th Apr 20264:00 pmRNSAnnual Financial Report
20th Mar 20262:00 pmRNSAdmission of Shares
18th Mar 20267:00 amRNSApproval to Trade on the OTCQB Venture Market
17th Mar 20264:33 pmRNSStrategic Investment by US investor group
6th Mar 20262:00 pmRNSBilateral Agreement - Lost Soldier Oil and Gas
6th Mar 20267:00 amRNSOTCQB Venture Market Application
27th Feb 20269:00 amRNSTR1
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
26th Feb 20267:00 amRNSBlock Participation Aceh, Indonesia
26th Feb 20267:00 amRNSTechnical Committee Appointment
18th Feb 20268:18 amRNSHigh-Impact Borneo and North Sumatra Opportunities
17th Feb 20267:00 amRNSStrategic Placement & Management Share Purchase
23rd Jan 20267:00 amRNSCorporate Announcement
22nd Jan 20267:00 amRNSAppointment of Strategic Advisor
9th Dec 202512:00 pmRNSRECEIPT of TR-1
4th Dec 20251:15 pmRNSAdmission of Shares
28th Nov 20255:00 pmRNSExercise of Options and Total Voting Rights
28th Nov 20257:00 amRNSDirector/PDMR Share Dealings
24th Nov 20255:00 pmRNSDirector/PDMR filing
24th Nov 20257:15 amRNSOptions Award
24th Nov 20257:00 amRNSCorporate Announcement
24th Oct 20252:00 pmRNSExecution Of Binding Contracts - Vanguard Drilling
1st Oct 20257:00 amRNSAcquisition Agreement Vanguard Drilling
30th Sep 20257:31 amRNSHalf-year Report
29th Jul 20257:56 amRNSResult of AGM
17th Jun 20257:00 amRNSNotice of 2025 Annual General Meeting (2025 AGM)
27th May 20257:03 amRNSHolding(s) in Company
19th May 20252:34 pmRNSAdmission of Shares
13th May 20257:00 amRNSDirector/PDMR Shareholding
9th May 20252:00 pmRNSOperational Update
8th May 20255:00 pmRNSDirectorate Change
29th Apr 20257:00 amRNSAnnual Financial Report
14th Apr 20257:05 amRNSShareholder Update
31st Mar 20257:00 amRNSNew Adviser
7th Mar 20254:58 pmRNSAdmission of Shares
3rd Mar 20254:30 pmRNSAdmission of Shares
3rd Mar 20257:00 amRNSExpiration of Warrants
28th Feb 20251:42 pmRNSWarrants Exercise
24th Feb 20254:30 pmRNSWarrants Exercise
21st Feb 20257:00 amRNSBoard Appointment
7th Oct 20248:28 amRNSHolding(s) in Company
7th Oct 20247:00 amRNSHolding(s) in Company
30th Sep 20247:00 amRNSHalf-year Report
30th Sep 20247:00 amRNSHolding(s) in Company
23rd Sep 20242:48 pmRNSAdmission of Shares
9th Sep 20247:00 amRNSStrategic Investor Subscription
4th Sep 20247:00 amRNSGovernment Discussions Update
28th Aug 20247:00 amRNSDirector/PDMR Shareholding
7th Aug 20249:30 amRNSDirector/PDMR Shareholding
5th Aug 20244:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.